UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                 AMENDMENT NO. 1
                                       TO

                                 SCHEDULE 14D-9

       Solicitation/Recommendation Statement Pursuant to Section 14(d)(4)
                     of the Securities Exchange Act of 1934

                            BellaVista Capital, Inc.
                            (Name of Subject Company)

                            BellaVista Capital, Inc.
                     (Name(s) of Person(s) Filing Statement)

                                  Common Stock
                         (Title of Class of Securities)

                                      None
                      (CUSP Number of Class of Securities)

                            Michael Rider, President
                              15700 Winchester Blvd
                          Los Gatos, California 950301
                               Tel (650) 328-3060

                                    Copy to:

                                 Paul Derenthal
                           Derenthal & Dannhauser LLP
                        1999 Harrison Street, 26th Floor
                            Oakland, California 94612
                            Telephone (510) 350-3070


 (Name, address (including zip code) and telephone number (including area code)
         of person(s) authorized to receive notices and communications
                  on behalf of the person(s) filing statement)

[ ] Check the box if the filing relates solely to preliminary communications
made before the commencement of a tender offer.





ITEM 1.  SUBJECT COMPANY INFORMATION.

     The name of the subject  company is  BellaVista  Capital,  Inc., a Maryland
corporation  (the "Company").  The address of the principal  executive office of
the  Company is 15700  Winchester  Blvd,  Los  Gatos,  CA 95030.  The  Company's
telephone number at that address is (650) 328-3060.

     The title of the class of equity securities to which this statement relates
is the Company's  Common Stock,  par value $0.01 per share (the  "Shares").  The
number of Shares outstanding as of as of July 30, 2008 was 11,805,817.

ITEM 2.  IDENTITY AND BACKGROUND OF FILING PERSON.

     This Schedule  14D-9 is being filed by the Company.  The name,  address and
telephone number of the Company are set forth in Item 1 above.

     This  Schedule  14D-9  relates to a tender  offer (the "MPF  Offer")  dated
August 1, 2008,  by MPF Badger  Acquisition  Co.,  LLC;  MPF DeWaay Fund 5, LLC;
Sutter  Opportunity  Fund 3, LLC; MP Value Fund 7, LLC;  and Sutter  Opportunity
Fund 4, LLC (collectively, "MPF") to purchase up to 400,000 Shares at a purchase
price  equal to $1.00 per Share,  less the amount of any  dividends  declared or
made with respect to the Shares  between August 1, 2008 and September 8, 2008 or
a later date to which the MPF Offer may be extended,  upon the terms and subject
to the conditions set forth in an MPF Offer to Purchase dated August 1, 2008.

     As set forth in MPF's  Schedule TO filed with the  Securities  and Exchange
Commission (the "SEC") on August 1, 2008, the principal executive offices of MPF
are located at 1640 School Street, Moraga, California 94556.

ITEM 3.  PAST CONTACTS, TRANSACTIONS, NEGOTIATIONS AND AGREEMENTS.

     Not applicable.

ITEM 4.  THE SOLICITATION OR RECOMMENDATION.

     The Company's  Board of Directors  (the "Board") has reviewed and carefully
considered  the MPF Offer and has concluded that the  consideration  provided by
the MPF Offer is inadequate to the shareholders of the Company. The MPF Offer is
the eighth in a sequential series of tender offers (seven prior offers have been
made,  in June and October,  2005,  April and October  2006,  June and September
2007,  and March  2008,  respectively).  All have been made at prices  which are
significantly  below what the Company  has  estimated  to be the net  realizable
value of its  assets.  There is no  market  for the  Shares  and there can be no
assurance as to when or whether the  Shareholders  will realize amounts equal to
the estimated asset values for the Shares.  As the Company announced that it did
not intend to make any redemptions until 2009, the MPF tender offers,  including
the current MPF Offer,  and the Company's tender offers in response to those MPF
offers,  have  provided the only  significant  opportunity  for liquidity to the
Shareholders  during the past three  years.  While the Board  believes  that the
price  offered by MPF is  substantially  below the value of the  Shares,  it has
nevertheless  concluded  that it will be in the best interest of the Company and
its  Shareholders to make a competing offer to acquire up to 750,000 Shares at a
price of $1.75 per Share (the "Company  Offer").  Though the Company Offer price
is also  substantially  below the estimated  asset value per Share,  the Company
recognizes  that  some  Shareholders  may  have a  pressing  need or  desire  to
liquidate their Shares at this time. The Company believes that it is in the best
interest of the Company and its  Shareholders  to provide these  Shareholders an
opportunity to liquidate at a price in excess of the MPF Offer price.

     The Board unanimously recommends that shareholders reject the MPF Offer and
not tender  their  Shares.  Shareholders  are urged to  carefully  consider  the
factors  set forth  herein  and the  information  set forth in the Letter to the
Shareholders,  dated as of  August  14,  2008,  filed as  Exhibit  (a)(1) to the
initial  Schedule  14d-9,  and  the  Supplement  to  the  Offer  and  Letter  to
Shareholders  dated  September 9, 2008,  copies of which are attached  hereto as
Exhibits  (a)(2)  and  (a)(3),  respectively,  and are  incorporated  herein  by
reference.  The Board remains neutral with respect to the Company Offer and does
not make any  recommendation  as to whether  you should  tender or refrain  from
tendering your shares in response to the Company Offer.


                                       1


     No  member  of the  Board  and none of the  Company's  executive  officers,
affiliates or subsidiaries intends to tender or sell any Shares in the MPF Offer
or the Company Offer.

ITEM 5.  PERSON/ASSETS, RETAINED, EMPLOYED, COMPENSATED OR USED.

     Not applicable.

ITEM 6.  INTEREST IN SECURITIES OF THE SUBJECT COMPANY.

     No applicable.

ITEM 7.  PURPOSES OF THE TRANSACTION AND PLANS OR PROPOSALS.

     Not applicable.

ITEM 8.  ADDITIONAL INFORMATION.

     The  information set forth in the Letter to the  Shareholders,  dated as of
March 20,  2008,  a copy of which is  attached  hereto  as  Exhibit  (a)(1)  and
incorporated herein by reference.

ITEM 9.  EXHIBITS.

     (a)(2)    Supplement Letter to Offer dated September 9, 2008
     (a)(3)    Letter to Shareholders dated September 9, 2008

     (e)       Not applicable.

     (g)       Not applicable.





                                    SIGNATURE

     After due inquiry  and to the best of my  knowledge  and belief,  I certify
that the information set forth in this statement is true, complete and correct.


Dated:   September 9, 2008                  BellaVista Capital, Inc


                                            /s/ MICHAEL RIDER
                                            -------------------------
                                            Name:    Michael Rider
                                            Title:   President









                                       2